Cognitive dysfunction and functional magnetic resonance imaging in systemic lupus erythematosus

Lupus

Volumn 24, Issue 12, 2015, Pages 1239-1247

  Barraclough, M ^a   Elliott, R ^b,c   McKie, S ^b,c   Parker, B ^a   Bruce, I N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

cognitive dysfunction; fMRI; SLE

Indexed keywords

ARTICLE; BRAIN FUNCTION; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; IMMUNOPATHOLOGY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SYSTEMIC LUPUS ERYTHEMATOSUS; BRAIN MAPPING; COGNITION DISORDERS; COMPLICATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BRAIN MAPPING; COGNITION; COGNITION DISORDERS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE;

EID: 84942116518     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315593819     Document Type: Article

References (52)

1. Tomietto P, Annese V, D ™agostini S, et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 2007; 57: 1461-1472.
2. Denburg SD, Denburg JA,. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 2003; 12: 883-890.
3. Benedict RH, Shucard JL, Zivadinov R, Shucard DW,. Neuropsychological impairment in systemic lupus erythematosus: A comparison with multiple sclerosis. Neuropsychol Rev 2008; 18: 149-166.
4. Conti F, Alessandri C, Perricone C, et al. Neurocognitive dysfunction in systemic lupus erythematosus: Association with antiphospholipid antibodies, disease activity and chronic damage. PLoS One 2012; 7: e33824-e33824.
5. Appenzeller S, Bonilha L, Rio PA, Min LL, Costallat LT, Cendes F,. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. Neuroimage 2007; 34: 694-701.
6. Harboe E, Greve OJ, Beyer M, et al. Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 2008; 79: 199-201.
7. Brey RL, Muscal E, Chapman J,. Antiphospholipid antibodies and the brain: A consensus report. Lupus 2011; 20: 153-157.
8. Luyendijk J, Steens SC, Ouwendijk WJ, et al. Neuropsychiatric systemic lupus erythematosus: Lessons learned from magnetic resonance imaging. Arthritis Rheum 2011; 63: 722-732.
9. Kozora E, Filley CM,. Cognitive dysfunction and white matter abnormalities in systemic lupus erythematosus. J Int Neuropsychol Soc 2011; 17: 385-392.
10. Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E,. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998; 41: 41-47.
11. Hill K, Mann L, Laws KR, Stephenson CM, Nimmo-Smith I, McKenna PJ,. Hypofrontality in schizophrenia: A meta-analysis of functional imaging studies. Acta Psychiatr Scand 2004; 110: 243-256.
12. Zardi EM, Taccone A, Marigliano B, Margiotta DP, Afeltra A,. Neuropsychiatric systemic lupus erythematosus: Tools for the diagnosis. Autoimmun Rev 2014; 13: 831-839.
13. Filley CM, Kozora E, Brown MS, et al. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus. Cogn Behav Neurol 2009; 22: 38-44.
14. Mackay M, Bussa MP, Aranow C, et al. Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration. Mol Med 2011; 17: 1349-1356.
15. Shapira-Lichter I, Vakil E, Litinsky I, et al. Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: A functional magnetic resonance imaging study. Lupus 2013; 22: 562-573.
16. DiFrancesco MW, Gitelman DR, Klein-Gitelman MS, et al. Functional neuronal network activity differs with cognitive dysfunction in childhood-onset systemic lupus erythematosus. Arthritis Res Ther 2013; 15: R40-R40.
17. DiFrancesco MW, Holland SK, Ris MD, et al. Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: A pilot study. Arthritis Rheum 2007; 56: 4151-4163.
18. Fitzgibbon BM, Fairhall SL, Kirk IJ, et al. Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls. Rheumatology (Oxford) 2008; 47: 50-53.
19. Hou J, Lin Y, Zhang W, et al. Abnormalities of frontal-parietal resting-state functional connectivity are related to disease activity in patients with systemic lupus erythematosus. PLoS One 2013; 8: e74530-e74530.
20. Mak A, Ren T, Fu EH, Cheak AA, Ho RC,. A prospective functional MRI study for executive function in patients with systemic lupus erythematosus without neuropsychiatric symptoms. Semin Arthritis Rheum 2012; 41: 849-858.
21. Ren T, Ho RC, Mak A,. Dysfunctional cortico-basal ganglia-thalamic circuit and altered hippocampal-amygdala activity on cognitive set-shifting in non-neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2012; 64: 4048-4059.
22. Dina B, Baker A, Sagcal-Gironella AC, et al. Preliminary findings of functional magnetic resonance imaging (fMRI) assessments of specific cognitive domains in childhood-onset systemic lupus erythematosus (cSLE) patients and best-friend controls. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 10, Philadelphia, PA, USA: John Willey and Sons Inc, 2010, pp. 1689-1689.
23. Fang Y, Zou Q,. The resting state and task based functional magnetic resonance imaging study in non-neuropsychiatric systemic lupus erythematosus. Arthritis and Rheumatism Annual Scientific Meeting of the American College of Rheumatology and Association of Rheumatology Health Professionals, Chicago, IL, USA: John Willey and Sons Inc, 2011.
24. Ho RCM, Fu E, Tao R, Mak A,. Functional magnetic resonance imaging (fMRI) study of feedback evaluation, response section and maintenance process during Wisconsin Card Sort Test in newly-diagnosed systemic lupus erythematosus. J Psychosom Res 2013; 74: 547-547.
25. Ho RC, Tao R, Mak A. A comparison of executive function in newly-diagnosed systemic lupus erythematosus (SLE) patients and controls: A functional magnetic resonance imaging (fMRI) study. Brain, Behavior, and Immunity 18th Annual Meeting of the PsychoNeuroImmunology Research Society-PsychoNeuroImmunology Mechanisms of Disease: From Pathophysiology to Prevention and Treatment, PNIRS. Chicago, IL, USA, 2011, p.S188.
26. Klein-Gitelman M, Cedeno A, Baker A, et al. Distinct functional activation and connectivity patterns for a visuo-constructional task in childhood-onset systemic lupus erythematosus and matched controls. Arthritis and Rheumatism Annual Scientific Meeting of the American College of Rheumatology and Association of Rheumatology Health Professionals, Chicago, IL, USA: John Willey and Sons Inc, 2011.
27. Mak A, Graham S, Ho EH, Ho YY, Ho RC. A prospective evaluation of cognitive function in patients with newly diagnosed systemic lupus erythematosus (SLE): Results of a pilot event-related functional magnetic resonance imaging (fMRI) study. International Journal of Rheumatic Diseases 14th Congress of Asia Pacific League of Associations for Rheumatology, APLAR. Hong Kong, 2010, pp.117-118.
28. Mak A, Ren T, Fu EHY, Cheak AAC, Ho RCM,. Inefficient strategic planning with compensatory recruitment of neural pathway for conflict processing and error detection despite sufficient disease control in patients with new onset systemic lupus erythematosus: A prospective functional MRI study. Arthritis and Rheumatism Annual Scientific Meeting of the American College of Rheumatology and Association of Rheumatology Health Professionals, Chicago, IL, USA: John Wiley and Sons Inc, 2011.
29. Paran D, Glikmann-Johnston I, Hendler T, et al. Increased recruitment of brain activation within the hippocampus in SLE patients as shown by functional MRI may be a compensatory mechanism to cope with memory impairment. Arthritis and Rheumatism American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 10, Philadelphia, PA, USA: John Willey and Sons Inc, 2010, pp. 1159-1159.
30. Sagcal-Gironella AC, Klein-Gitelman M, Baker A, et al. Preliminary findings of functional magnetic resonance imaging (fMRI) assessments of visuoconstructional ability in childhood-onset systemic lupus erythematosus (cSLE) patients and best-friend controls. Arthritis and Rheumatism American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 09, Atlanta, GA, USA: John Willey and Sons Inc, 2009, pp. 1534-1534.
31. Callicott JH, Bertolino A, Mattay VS, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000; 10: 1078-1092.
32. Wager TD, Smith EE,. Neuroimaging studies of working memory: A meta-analysis. Cogn Affect Behav Neurosci 2003; 3: 255-274.
33. Chung GH, Han YM, Jeong SH, Jack CR Jr,. Functional heterogeneity of the supplementary motor area. AJNR Am J Neuroradiol 2005; 26: 1819-1823.
34. Kozora E, Filley CM, Zhang L, et al. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations. Lupus 2012; 21: 402-411.
35. Kowal C, Degiorgio LA, Lee JY, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006; 103: 19854-19859.
36. Diamond B, Volpe BT,. A model for lupus brain disease. Immunol Rev 2012; 248: 56-67.
37. Matus S, Burgos PV, Bravo-Zehnder M, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 2007; 204: 3221-3234.
38. Hillary FG, Genova HM, Chiaravalloti ND, Rypma B, DeLuca J,. Prefrontal modulation of working memory performance in brain injury and disease. Hum Brain Mapp 2006; 27: 837-847.
39. Grillon ML, Oppenheim C, Varoquaux G, et al. Hyperfrontality and hypoconnectivity during refreshing in schizophrenia. Psychiatry Res 2013; 211: 226-233.
40. Callicott JH, Mattay VS, Bertolino A, et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 1999; 9: 20-26.
41. Paran D, Ash E, Litinsky I, et al. Impaired diffusion tensor imaging findings in the corpus callosum and cingulum may underlie impaired learning and memory abilities in systemic lupus erythematosus. Arthritis Rheum 2012; 64(Suppl 10): 611.
42. Guerrero-Pedraza A, McKenna PJ, Gomar JJ, et al. First-episode psychosis is characterized by failure of deactivation but not by hypo- or hyperfrontality. Psychol Med 2012; 42: 73-84.
43. Lin Y, Zou QH, Wang J, et al. Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus. Hum Brain Mapp 2011; 32: 1847-1855.
44. Gitelman DR, Klein-Gitelman MS, Ying J, et al. Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit. Arthritis Rheum 2013; 65: 2190-2200.
45. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K,. Neuropsychiatric events in systemic lupus erythematosus: Attribution and clinical significance. J Rheumatol 2004; 31: 2156-2162.
46. Fangtham M, Petri M,. 2013 update: Hopkins lupus cohort. Curr Rheumatol Rep 2013; 15: 360-360.
47. Erkan D, Vega J, RamÏŒn G, Kozora E, Lockshin MD,. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum 2013; 65: 464-471.
48. Mekinian A, Ravaud P, Larroche C, et al. Rituximab in central nervous system manifestations of patients with primary Sjögren ™s syndrome: Results from the AIR registry. Clin Exp Rheumatol 2012; 30: 208-212.
49. Tokunaga M, Saito K, Kawabata D, et al. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis 2007; 66: 470-475.
50. McLaurin EY, Holliday SL, Williams P, Brey RL,. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64: 297-303.
51. Lim LS, Lefebvre A, Benseler S, Silverman ED,. Longterm outcomes and damage accrual in patients with childhood systemic lupus erythematosus with psychosis and severe cognitive dysfunction. J Rheumatol 2013; 40: 513-519.
52. Denburg SD, Carbotte RM, Denburg JA,. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1311-1320.